OCM
CATX icon

Osterweis Capital Management’s Perspective Therapeutics CATX Stock Holding History

Osterweis Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-91,293
Closed -$1.22M – 198
2024
Q3 		$1.22M Hold
91,293
– – 0.06% 102
2024
Q2 		$910K Sell
91,293
-33,200
-27% -$480K 0.05% 103
2024
Q1 		$1.48M Sell
124,493
-33,717
-21% -$288K 0.09% 92
2023
Q4 		$636K Hold
158,210
– – 0.04% 106
2023
Q3 		$433K Hold
158,210
– – 0.03% 113
2023
Q2 		$1.06M Hold
158,210
– – 0.07% 100
2023
Q1 		$1.01M Buy
+158,210
New +$646K 0.07% 106

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Osterweis Capital Management's CATX Position: Q4 2024 in Review

Osterweis Capital Management sold out of Perspective Therapeutics (CATX) in Q4 2024, closing a stake of 91,293 shares — an estimated $1.22M sold.

Osterweis Capital Management first reported a position in CATX in Q1 2023 and held it in 7 quarters. The position peaked at $1.48M in Q1 2024. 135 funds tracked by Wall St. Rank hold CATX as of Q4 2024.

  • Osterweis Capital Management reported no remaining Perspective Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Osterweis Capital Management sold 91,293 Perspective Therapeutics shares in Q4 2024, an estimated $1.22M.
  • Osterweis Capital Management first reported a position in Perspective Therapeutics in Q1 2023 and held it in 7 quarters.
  • Osterweis Capital Management's Perspective Therapeutics position peaked at $1.48M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2024.

Based on Osterweis Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.